• 中文
    • 登錄
    • 聯系我們
    ×
    目錄產品 » 抗體產品 » 一抗 » 免疫檢查點抗體和蛋白 » Anti-Nivolumab Antibody(8G6G3D8), mAb, Mouse
    Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse

    Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse (GenScript, A01847-40) binds with Nivolumab, while the antibody does not recognize human IgG Fc fragment (data not shown).
    Coating antigen: Nivolumab, 1 μg/ml.
    Anti-Nivolumab antibody (GenScript, A01847-40) dilution start from 1,000 ng/ml.
    EC??= 2.72 ng/ml.

    Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse

    Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse (GenScript, A01847-40) binds with Nivolumab,while the antibody does not recognize human IgG Fc fragment (data not shown).
    Coating antigen: Nivolumab, 1 μg/ml.
    Anti-Nivolumab antibody (GenScript, A01847-40) dilution start from 1,000 ng/ml.
    EC??= 2.72 ng/ml.

    Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse

    Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse (GenScript, A01847-40) binds with Nivolumab, while the antibody does not recognize human IgG Fc fragment (data not shown).
    Coating antigen: Nivolumab, 1 μg/ml.
    Anti-Nivolumab antibody (GenScript, A01847-40) dilution start from 1,000 ng/ml.
    EC??= 2.72 ng/ml.

    Anti-Nivolumab Antibody(8G6G3D8), mAb, Mouse

    The product is specific for Nivolumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01848-40, Anti- Nivolumab Antibody (6G5H2E6), mAb, Mouse.
    A01847
    ¥990

    聯系我們
    Specificity The product is specific for Nivolumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01848-40, Anti- Nivolumab Antibody (6G5H2E6), mAb, Mouse.
    Host Species Mouse
    Immunogen Nivolumab
    Conjugate Unconjugated

    Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
    Application Recommended Usage
    ELISA 0.01-0.1 μg/ml

    Form Lyophilized
    Storage Buffer lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
    Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL.
    Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
    Purification Protein A affinity column
    Isotype Mouse IgG1
    Clonality Monoclonal
    Clone ID 8G6G3D8

    • Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse
    • Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse

      Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse (GenScript, A01847-40) binds with Nivolumab, while the antibody does not recognize human IgG Fc fragment (data not shown).
      Coating antigen: Nivolumab, 1 μg/ml.
      Anti-Nivolumab antibody (GenScript, A01847-40) dilution start from 1,000 ng/ml.
      EC??= 2.72 ng/ml.

    • Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse
    • Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse

      Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse (GenScript, A01847-40) binds with Nivolumab,while the antibody does not recognize human IgG Fc fragment (data not shown).
      Coating antigen: Nivolumab, 1 μg/ml.
      Anti-Nivolumab antibody (GenScript, A01847-40) dilution start from 1,000 ng/ml.
      EC??= 2.72 ng/ml.

    • Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse
    • Anti-Nivolumab Antibody(8G6G3D8), MAb, Mouse

      Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse (GenScript, A01847-40) binds with Nivolumab, while the antibody does not recognize human IgG Fc fragment (data not shown).
      Coating antigen: Nivolumab, 1 μg/ml.
      Anti-Nivolumab antibody (GenScript, A01847-40) dilution start from 1,000 ng/ml.
      EC??= 2.72 ng/ml.


    Target Background Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Nivolumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.GenScript Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Nivolumab.
    Synonyms Mouse monoclonal to Opdivo

    For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


    国产小受呻吟cv视频在线观看